[HTML][HTML] Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
XQ Zhou, YP Li, SS Dang - World Journal of Hepatology, 2024 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poses a
major challenge to global health due to its high morbidity and mortality. Conventional …
major challenge to global health due to its high morbidity and mortality. Conventional …
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy.
XQ Zhou, YP Li, SS Dang - World Journal of Hepatology, 2024 - europepmc.org
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poses a
major challenge to global health due to its high morbidity and mortality. Conventional …
major challenge to global health due to its high morbidity and mortality. Conventional …
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
XQ Zhou, YP Li, SS Dang - World journal of hepatology, 2024 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poses a
major challenge to global health due to its high morbidity and mortality. Conventional …
major challenge to global health due to its high morbidity and mortality. Conventional …
[PDF][PDF] WJH
XQ Zhou, YP Li, SS Dang - World, 2024 - researchgate.net
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poses a
major challenge to global health due to its high morbidity and mortality. Conventional …
major challenge to global health due to its high morbidity and mortality. Conventional …
WJH
XQ Zhou, YP Li, SS Dang - World, 2024 - europepmc.org
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poses a
major challenge to global health due to its high morbidity and mortality. Conventional …
major challenge to global health due to its high morbidity and mortality. Conventional …